Matchpoint Therapeutics

aid: matchpoint-therapeutics
name: Matchpoint Therapeutics
description: Matchpoint Therapeutics is a privately held biotechnology company headquartered in Watertown, Massachusetts —
  Cambridge at launch — that discovers precision small-molecule covalent medicines intended to transform the treatment of
  immune diseases and other serious illness. It was founded by covalent-chemistry, proteomics and computational-science researchers
  from Stanford University and Harvard Medical School, closed a $30 million seed round co-led by Atlas Venture and Access
  Biotechnology in November 2021, and launched publicly in October 2022 with $100 million in total financing after a $70 million
  Series A led by Sanofi Ventures with Vertex Ventures HC, Digitalis Ventures and Alexandria Venture Investments. Its proprietary
  Advanced Covalent Exploration (ACE) platform combines industry-leading chemoproteomics that detects allosteric, transient
  and cryptic binding pockets in native cells, machine-learning algorithms that prioritise targets and guide medicinal chemistry,
  and a continuously evolving proprietary library of covalent compounds spanning fragments through drug-like leads. In July
  2025 Matchpoint entered an exclusive option and licence agreement with Novartis to develop oral covalent inhibitors against
  a transcription factor linked to multiple inflammatory diseases, worth up to $60 million upfront and in research funding
  and up to $1 billion in total potential payments. Matchpoint runs no developer program and publishes no product API, developer
  portal, API reference or SDK. The only machine-readable surface reachable without credentials is the WordPress REST content
  API behind matchpointtx.com, catalogued here.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: true
  label: Hosted service · you call their endpoint
  confidence: high
  source:
  - openapi
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: open
  trial: false
  try_now: false
  public: true
  gated: none
  gated_source:
  - onboarding
  label: Open access
  confidence: medium
  source:
  - authentication
  - rate-limits
  - security
  generated: '2026-11-02'
  method: derived
image: https://matchpointtx.com/wp-content/uploads/2022/09/logo-matchpoint.png
url: https://raw.githubusercontent.com/api-evangelist/matchpoint-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.23'
created: '2026-08-25'
modified: '2026-08-25'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Immunology
- Covalent Chemistry
- chemoproteomics
- Machine Learning
- Life Sciences
- content-api
tags_raw:
- Company
- biotechnology
- pharmaceuticals
- drug-discovery
- immunology
- covalent-chemistry
- chemoproteomics
- machine-learning
- life-sciences
- content-api
- Machine-Learning
apis:
- aid: matchpoint-therapeutics:matchpointtx-com-website-wordpress-rest
  name: Matchpoint Therapeutics Website (WordPress REST)
  description: 'The public WordPress REST API (wp-json) of the Matchpoint Therapeutics website at matchpointtx.com: the route
    index of the site''s content management system, catalogued as one site surface rather than as separate APIs.'
  baseURL: https://matchpointtx.com/wp-json
  tags:
  - WordPress
  x-surface: platform-generated
  properties:
  - type: Documentation
    url: https://matchpointtx.com/wp-json
  x-platform: wordpress
  x-platform-surface: rest
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://matchpointtx.com/
- type: BlogRSS
  url: https://matchpointtx.com/feed/
- type: Careers
  url: https://boards.greenhouse.io/matchpointtx
- type: PrivacyPolicy
  url: https://matchpointtx.com/privacy-policy/
- type: TermsOfService
  url: https://matchpointtx.com/terms-conditions/
- type: LinkedIn
  url: https://www.linkedin.com/company/matchpoint-therapeutics
- type: Twitter
  url: https://twitter.com/matchpointtx
- type: SecondaryMarket
  url: https://www.nasdaqprivatemarket.com/company/matchpoint-therapeutics/
- type: SecondaryMarket
  url: https://equityzen.com/company/matchpointtherapeutics/
- type: Authentication
  url: authentication/matchpoint-therapeutics-authentication.yml
- type: Conventions
  url: conventions/matchpoint-therapeutics-conventions.yml
- type: Conformance
  url: conformance/matchpoint-therapeutics-conformance.yml
- type: ErrorCatalog
  url: errors/matchpoint-therapeutics-problem-types.yml
- type: Lifecycle
  url: lifecycle/matchpoint-therapeutics-lifecycle.yml
- type: DataModel
  url: data-model/matchpoint-therapeutics-data-model.yml
- type: DomainSecurity
  url: security/matchpoint-therapeutics-domain-security.yml
- type: Packages
  url: packages/matchpoint-therapeutics-packages.yml
- type: Plans
  url: plans/matchpoint-therapeutics-plans-pricing.yml
- type: RateLimits
  url: rate-limits/matchpoint-therapeutics-rate-limits.yml
- type: LLMsTxt
  url: llms/matchpoint-therapeutics-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-25'
  status: enriched
  artifacts_added: 27
  pass: local-v1